Cargando…
The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
CONTEXT: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). AIMS: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. SETTING AND DESIGN: This was a cross-sect...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513958/ https://www.ncbi.nlm.nih.gov/pubmed/34728950 http://dx.doi.org/10.4103/aian.AIAN_1151_20 |
_version_ | 1784583302033702912 |
---|---|
author | Negalur, Natasha Vijay Ekbote, Gayatri G. Raval, Dhiren N. Tanna, Dhaval V. Kazi, Wasim S. Bindroo, Muzaffar A. Yadavalli, Durgarao J. Gupta, Rajiva |
author_facet | Negalur, Natasha Vijay Ekbote, Gayatri G. Raval, Dhiren N. Tanna, Dhaval V. Kazi, Wasim S. Bindroo, Muzaffar A. Yadavalli, Durgarao J. Gupta, Rajiva |
author_sort | Negalur, Natasha Vijay |
collection | PubMed |
description | CONTEXT: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). AIMS: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. SETTING AND DESIGN: This was a cross-sectional observational study. METHODS AND MATERIALS: Consecutive AIM patents were divided into groups as dermatomyositis (DM), polymyositis (PM), CTD-associated myositis (CTD-M), cancer-associated myositis (CAM) and juvenile myositis (JM). Their data along with serum samples were collected after obtaining informed consent. Sera was analyzed for IgG antibodies against Jo-1, PL-7, PL-12, EJ, SRP, Mi-2, MDA-5, TIF1γ, SAE1, SAE2, NXP2 and SSA/R052kD using the microELISA technique. The institutional ethics committee approved the study. STATISTICAL ANALYSIS: SPSS software (version 24.0) was used. P value < 0.05 was considered statistically significant. RESULTS: There were 48 patients (DM = 19, PM = 19, CTD-M = 5, CAM = 2, JM = 3) included. MSA were positive in 37.5% patients. Antibodies against Mi-2 were present in 6 (12.5%), Jo-1 in 5 (10.4%), 2 (4.1%) each had PL-7 and SRP antibodies. One patient (2%) each had MDA-5, NXP2 and TIf1g antibodies. Jo-1 antibody was associated with mechanic's hands and ILD. There was a significant association of rash in the Mi-2 group with none of the patients having ILD. Malignancy screening was negative in NXP2 and TIF1g antibody-positive patients. Ro52 was the most common MAA (33.3%) and was associated with mechanic's hand. CONCLUSION: MSA was present in almost 40% of the cohort. Anti Jo-1 antibody was associated with mechanic's hands and ILD. None of the Mi-2 patients had ILD, which may point to a protective role of this antibody for ILD. The association of newer antibodies in Indian patients needs to be further studied in larger cohorts. |
format | Online Article Text |
id | pubmed-8513958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-85139582021-11-01 The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients Negalur, Natasha Vijay Ekbote, Gayatri G. Raval, Dhiren N. Tanna, Dhaval V. Kazi, Wasim S. Bindroo, Muzaffar A. Yadavalli, Durgarao J. Gupta, Rajiva Ann Indian Acad Neurol Original Article CONTEXT: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). AIMS: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. SETTING AND DESIGN: This was a cross-sectional observational study. METHODS AND MATERIALS: Consecutive AIM patents were divided into groups as dermatomyositis (DM), polymyositis (PM), CTD-associated myositis (CTD-M), cancer-associated myositis (CAM) and juvenile myositis (JM). Their data along with serum samples were collected after obtaining informed consent. Sera was analyzed for IgG antibodies against Jo-1, PL-7, PL-12, EJ, SRP, Mi-2, MDA-5, TIF1γ, SAE1, SAE2, NXP2 and SSA/R052kD using the microELISA technique. The institutional ethics committee approved the study. STATISTICAL ANALYSIS: SPSS software (version 24.0) was used. P value < 0.05 was considered statistically significant. RESULTS: There were 48 patients (DM = 19, PM = 19, CTD-M = 5, CAM = 2, JM = 3) included. MSA were positive in 37.5% patients. Antibodies against Mi-2 were present in 6 (12.5%), Jo-1 in 5 (10.4%), 2 (4.1%) each had PL-7 and SRP antibodies. One patient (2%) each had MDA-5, NXP2 and TIf1g antibodies. Jo-1 antibody was associated with mechanic's hands and ILD. There was a significant association of rash in the Mi-2 group with none of the patients having ILD. Malignancy screening was negative in NXP2 and TIF1g antibody-positive patients. Ro52 was the most common MAA (33.3%) and was associated with mechanic's hand. CONCLUSION: MSA was present in almost 40% of the cohort. Anti Jo-1 antibody was associated with mechanic's hands and ILD. None of the Mi-2 patients had ILD, which may point to a protective role of this antibody for ILD. The association of newer antibodies in Indian patients needs to be further studied in larger cohorts. Wolters Kluwer - Medknow 2021 2021-05-21 /pmc/articles/PMC8513958/ /pubmed/34728950 http://dx.doi.org/10.4103/aian.AIAN_1151_20 Text en Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Negalur, Natasha Vijay Ekbote, Gayatri G. Raval, Dhiren N. Tanna, Dhaval V. Kazi, Wasim S. Bindroo, Muzaffar A. Yadavalli, Durgarao J. Gupta, Rajiva The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients |
title | The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients |
title_full | The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients |
title_fullStr | The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients |
title_full_unstemmed | The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients |
title_short | The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients |
title_sort | association of myositis specific antibodies in patients with inflammatory myositis: preliminary data in indian patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513958/ https://www.ncbi.nlm.nih.gov/pubmed/34728950 http://dx.doi.org/10.4103/aian.AIAN_1151_20 |
work_keys_str_mv | AT negalurnatashavijay theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT ekbotegayatrig theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT ravaldhirenn theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT tannadhavalv theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT kaziwasims theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT bindroomuzaffara theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT yadavallidurgaraoj theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT guptarajiva theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT negalurnatashavijay associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT ekbotegayatrig associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT ravaldhirenn associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT tannadhavalv associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT kaziwasims associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT bindroomuzaffara associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT yadavallidurgaraoj associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients AT guptarajiva associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients |